JP2019506183A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019506183A5 JP2019506183A5 JP2018560445A JP2018560445A JP2019506183A5 JP 2019506183 A5 JP2019506183 A5 JP 2019506183A5 JP 2018560445 A JP2018560445 A JP 2018560445A JP 2018560445 A JP2018560445 A JP 2018560445A JP 2019506183 A5 JP2019506183 A5 JP 2019506183A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sample
- group
- mirna
- determining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 17
- 108091070501 miRNA Proteins 0.000 claims 16
- 239000002679 microRNA Substances 0.000 claims 16
- 208000018737 Parkinson disease Diseases 0.000 claims 4
- 210000001124 body fluid Anatomy 0.000 claims 4
- 239000010839 body fluid Substances 0.000 claims 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 238000011529 RT qPCR Methods 0.000 claims 1
- 230000000692 anti-sense effect Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 238000002493 microarray Methods 0.000 claims 1
- 238000007481 next generation sequencing Methods 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291619P | 2016-02-05 | 2016-02-05 | |
| US62/291,619 | 2016-02-05 | ||
| PCT/US2017/016412 WO2017136662A1 (en) | 2016-02-05 | 2017-02-03 | Circulating serum microrna biomarkers and methods for determining parkinson's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019506183A JP2019506183A (ja) | 2019-03-07 |
| JP2019506183A5 true JP2019506183A5 (cg-RX-API-DMAC7.html) | 2020-01-23 |
| JP7197755B2 JP7197755B2 (ja) | 2022-12-28 |
Family
ID=58094505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560445A Active JP7197755B2 (ja) | 2016-02-05 | 2017-02-03 | 循環血清マイクロｒｎａバイオマーカー及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11499184B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3985130A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7197755B2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2947634T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017136662A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018236589A1 (en) * | 2017-06-19 | 2018-12-27 | St. John's University | Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis |
| US20220042099A1 (en) * | 2018-10-18 | 2022-02-10 | Quadrant Biosciences Inc. | Molecular and functional characterization of early-stage parkinson's disease and treatments therein |
| CA3139919A1 (en) * | 2019-03-11 | 2020-09-17 | Ochsner Health System | Microrna regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage |
| WO2020213699A1 (ja) * | 2019-04-17 | 2020-10-22 | 京都府公立大学法人 | 自己免疫疾患及び／又は炎症性疾患の判定方法、並びに炎症性疾患及び／又は自己免疫疾患の予防及び／又は治療剤 |
| CN111073973A (zh) * | 2019-12-10 | 2020-04-28 | 石河子大学 | 一种用于早期诊断2型糖尿病的microRNA序列及其应用 |
| CN115605608A (zh) | 2020-05-14 | 2023-01-13 | 花王株式会社（Jp） | 帕金森氏病的检测方法 |
| US20240410857A1 (en) * | 2021-01-27 | 2024-12-12 | Beth Israel Deaconess Medical Center | Electrophoretic mobility shift as a molecular beacon-based readout for mirna detection |
| WO2023050642A1 (zh) * | 2021-09-29 | 2023-04-06 | 南京凡亦达生物科技有限公司 | 甲胎蛋白或癌胚抗原联合基因标志物在肿瘤诊断中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140302068A1 (en) | 2011-09-09 | 2014-10-09 | The Regents Of The University Of Colorado | MicroRNA Biomarkers for Diagnosing Parkinson's Disease |
| WO2014018650A1 (en) | 2012-07-25 | 2014-01-30 | Rush University Medical Center | Mirnas as novel therapeutic targets and diagnostic biomarkers for parkinson's disease |
| US10011873B2 (en) * | 2012-11-16 | 2018-07-03 | Universitat Des Saarlandes | Diagnostic miRNA markers for Parkinson disease |
| WO2014179765A2 (en) * | 2013-05-02 | 2014-11-06 | Thomas Jefferson University | Novel human mirnas for use in diagnosis, prognosis and therapy of human conditions and diseases |
| US10961579B2 (en) | 2013-12-19 | 2021-03-30 | Hummingbird Diagnostics Gmbh | miRNAs as non-invasive biomarkers for Parkinson's disease |
| WO2015106273A2 (en) * | 2014-01-13 | 2015-07-16 | Trustees Of Boston University | Methods and assays relating to huntingtons disease and parkinson's disease |
-
2017
- 2017-02-03 US US16/075,354 patent/US11499184B2/en active Active
- 2017-02-03 WO PCT/US2017/016412 patent/WO2017136662A1/en not_active Ceased
- 2017-02-03 JP JP2018560445A patent/JP7197755B2/ja active Active
- 2017-02-03 EP EP21198200.4A patent/EP3985130A1/en active Pending
- 2017-02-03 EP EP17706344.3A patent/EP3411500B9/en active Active
- 2017-02-03 ES ES17706344T patent/ES2947634T3/es active Active
-
2022
- 2022-10-07 US US18/045,065 patent/US20230323442A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019506183A5 (cg-RX-API-DMAC7.html) | ||
| Fay et al. | RNA G-quadruplexes in biology: principles and molecular mechanisms | |
| US20240352454A1 (en) | Multi-effector crispr based diagnostic systems | |
| Akhoundi et al. | Leishmania infections: Molecular targets and diagnosis | |
| CN112020562B (zh) | 基于crispr效应系统的诊断 | |
| CN111108220B (zh) | 用于病毒检测的基于crispr效应系统的诊断 | |
| JP2014239695A5 (cg-RX-API-DMAC7.html) | ||
| JP2016195614A5 (cg-RX-API-DMAC7.html) | ||
| Malz et al. | Overexpression of far upstream element (FUSE) binding protein (FBP)‐interacting repressor (FIR) supports growth of hepatocellular carcinoma | |
| JP2016000057A5 (cg-RX-API-DMAC7.html) | ||
| EP4520841A3 (en) | Enzyme- and amplification-free sequencing | |
| JP2014532428A5 (cg-RX-API-DMAC7.html) | ||
| Zhou et al. | Circulating exosomal microRNAs as emerging non‐invasive clinical biomarkers in heart failure: mega bio‐roles of a nano bio‐particle | |
| JP2019524884A5 (cg-RX-API-DMAC7.html) | ||
| RU2017100253A (ru) | Набор или устройство для обнаружения рака предстательной железы и способ обнаружения | |
| WO2016161375A3 (en) | Methods of using oligonucleotide-guided argonaute proteins | |
| JP2016533708A5 (cg-RX-API-DMAC7.html) | ||
| WO2017136662A4 (en) | Circulating serum microrna biomarkers and methods for determining parkinson's disease | |
| Abrahem et al. | Formation of an RNA polymerase II preinitiation complex on an RNA promoter derived from the hepatitis delta virus RNA genome | |
| BR112014026440A2 (pt) | assays, methods and apparatus for assessing rna disruption | |
| CN102703455B (zh) | 一种人心肌肌钙蛋白i适配子及筛选方法和应用 | |
| JP2017521086A5 (cg-RX-API-DMAC7.html) | ||
| JP2015119721A5 (cg-RX-API-DMAC7.html) | ||
| JP2018534946A5 (cg-RX-API-DMAC7.html) | ||
| CN110191964A (zh) | 确定生物样本中预定来源的游离核酸比例的方法及装置 |